If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,970.00    -20.00 (-1.01%)
Bid:
1,930.00
Ask:
1,990.00
Spread: 60.00 (3.109%)
Market Cap: £239.37m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Update on Advantage Finance Limited

29 Oct 2024 14:00

RNS Number : 0759K
S & U PLC
29 October 2024
 

29 October 2024

S&U plc

("S&U" or "the Group")

Update on Advantage Finance Limited

 

S&U, the specialist motor and property financier, today notes the recent Court of Appeal decisions on Johnson and Wrench v Firstrand Bank Limited and Hopcraft v Close Brothers Limited, the implications of which it is considering. These decisions provide guidance for lower courts on the subject of commissions disclosure in the financial services industry. They unexpectedly overturned hitherto received judicial positions on the duties of motor dealers, credit brokers and lenders to disclose and obtain consent for the payment of commission. The Group also notes the intention of those companies to appeal those decisions to the UK Supreme Court.

 

The Court of Appeal decisions set a higher bar for the disclosure of, and consent to, the existence, nature, and quantum of any commission paid than that required by current FCA rules, as adhered to by regulated motor finance firms including the Group's motor finance subsidiary Advantage Finance Limited ("Advantage Finance"). However, the Court of Appeal recognised the 'tensions' between previous lower court judgements on the extent of commission disclosure in the cases of 'Hurstanger' and 'Wood'. It therefore called for 'a definitive announcement to be made by the Supreme Court about the circumstances in which the payment of a commission …. will give rise to a liability …. on the part of the payer.' It is therefore unsurprising that it is the intention of the companies involved to appeal the judgement to the UK Supreme Court.

 

In the meantime, S&U notes that these decisions do not specifically relate to 'difference in charges' models of commission (currently the subject of an FCA review) in which Advantage Finance has never been engaged.

 

Given the Court of Appeal's judgement and its implications for the whole of the financial services industry, S&U is aware that it has been the subject of urgent discussions between the FLA, the FCA and the Government, and looks for an expeditious resolution to the issue.

 

The Group will update the market, if and as appropriate.

 

 

 

 

ENDS

 

 

For further information, please contact:

Enquiries

Anthony Coombs

S&U plc

c/o SEC Newgate

Financial Public Relations

Bob Huxford, Molly Gretton, Harry Handyside

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Oliver Jackson

Peel Hunt LLP

020 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSLIDLAFIS
Date   Source Headline
1st Jul 20263:09 pmRNSDirector/PDMR Dealing
24th Jun 20261:00 pmRNSResult of AGM
12th Jun 20263:01 pmRNSDirector/PDMR Dealing
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.